Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Chronic Kidney Disease Clinical Trials
Chronic Kidney Disease clinical trials are recruiting across 145 cities. Here are the cities with the most active studies:
Chronic Kidney Disease Trial Phases
75 research organizations are sponsoring chronic kidney disease trials.
About Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.
Clinical trials are advancing new treatments for chronic kidney disease. Currently, 100 studies are recruiting a combined 151,451 participants across the United States. Research is being conducted by 75 organizations including Bayer, Tufts Medical Center, Indiana University and 72 others.
2026 Chronic Kidney Disease Research Landscape
As of July 2026, the chronic kidney disease clinical trial landscape includes 100 actively recruiting studies across 145 cities in the United States. These studies are collectively seeking 151,451 participants, with an average enrollment target of 1,515 per study.
The research spans multiple phases of development: 38 studies are in NA, 18 studies are in PHASE2, 13 studies are in PHASE3, 10 studies are in PHASE1, 6 studies are in PHASE4, 2 studies are in EARLY_PHASE1. The presence of Phase 3 trials indicates that some chronic kidney disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 75 different organizations, including Bayer, Tufts Medical Center, Indiana University, Renalytix AI, Inc., AstraZeneca, and 70 others. The large number of sponsors reflects significant research interest and investment in chronic kidney disease treatment advancement.
Geographically, chronic kidney disease trials are most concentrated in New York, New York (12 trials); Atlanta, Georgia (11 trials); Chicago, Illinois (11 trials); Boston, Massachusetts (11 trials); Los Angeles, California (9 trials) and 7 other cities.
Featured Chronic Kidney Disease Studies
Highlighted recruiting studies for chronic kidney disease, selected by enrollment size and research scope.
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
This is an observational study, in which data from people in Asia and in the United States with chronic kidney disease (CKD) together with type 2 diabetes (T2D) are studied. The participants in this study are already receiving the study treatment finerenone as part of their regular care from their doctors. In observational studies, only observations are made without specified advice or interventio...
The KidneyCARE (Community Access to Research Equity) Study
For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the KidneyCARE Study (kidneycarestudy.org). The KidneyC...
RaDIANT Health Systems Intervention
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Frequently Asked Questions About Chronic Kidney Disease Clinical Trials
Are there chronic kidney disease clinical trials near me?
Yes, there are 100 chronic kidney disease clinical trials currently recruiting across 145+ cities in the United States, including New York, New York; Atlanta, Georgia; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a chronic kidney disease clinical trial?
To join a chronic kidney disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are chronic kidney disease clinical trials free?
Yes, participation in chronic kidney disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of chronic kidney disease treatments are being studied?
Current chronic kidney disease clinical trials are testing a range of approaches across NA (38 studies), PHASE2 (18 studies), PHASE3 (13 studies), PHASE1 (10 studies), PHASE4 (6 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 75 research organizations.
Is it safe to participate in chronic kidney disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov